How Pluronic P85 Helps Treat Resistant Cancer Cells
Author Information
Author(s): Batrakova E V, Li S, Elmquist W F, Miller D W, Alakhov V Y, Kabanov A V
Primary Institution: College of Pharmacy, Department of Pharmaceutical Sciences, Nebraska Medical Center
Hypothesis
Can Pluronic P85 selectively deplete energy in multidrug-resistant (MDR) cancer cells to enhance the effectiveness of chemotherapy?
Conclusion
Pluronic P85 significantly reduces ATP levels in MDR cancer cells, making them more sensitive to chemotherapy drugs like doxorubicin.
Supporting Evidence
- Pluronic P85 reduces ATP levels selectively in MDR cancer cells.
- MDR cells are more responsive to Pluronic treatment compared to non-MDR cells.
- Pluronic acts as a chemosensitizer, enhancing the effects of doxorubicin.
Takeaway
Pluronic P85 is like a special helper that makes stubborn cancer cells weaker by taking away their energy, so they can be treated better with medicine.
Methodology
The study involved exposing various cancer cell lines to Pluronic P85 and measuring ATP levels and cytotoxicity in response to doxorubicin.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website